Karyopharm Therapeutics Inc. (KPTI)
NMS – Real vaqt narxi. Valyuta: USD
10.21
+0.75 (7.93%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
10.18
-0.03 (-0.29%)
Bozordan keyin: Jun 26, 2026, 7:42 PM EDT
Find any stock by ticker or company name

NMS – Real vaqt narxi. Valyuta: USD
10.21
+0.75 (7.93%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
10.18
-0.03 (-0.29%)
Bozordan keyin: Jun 26, 2026, 7:42 PM EDT
No Data
Ushbu aksiya uchun yangiliklar yo'q.
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 1.08 | 6.05 | 7.0 | |
| Tezkor likvidlik nisbati | 1.05 | 5.63 | 7.0 | |
| Qarz/Kapital nisbati | N/A | 0.30 | 1.0 | |
| Qarz/Aktivlar nisbati | 1.76 | 1.04 | 1.0 | |
| Foiz to‘lov qoplami | -2.13 | -16.91 | 1.0 | |
| O‘rtacha ball | 3.4 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | 157M | 146M | 145M | 146M | 151M |
| Yalpi foyda | 151M | 141M | 139M | 140M | 145M |
| Operatsion daromad | -142M | -130M | -119M | -91M | -84M |
| Sof foyda | -165M | -143M | -76M | -196M | -195M |
| EBITDA | -142M | -129M | -119M | -90M | -84M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | -12.68 | 69.68 | 5.5 |
| Keyingi chorak | -23.16 | 75.06 | 5.5 |
| Joriy yil | -6.06 | 77.24 | 5.5 |
| Keyingi yil | 13.18 | 23.53 | 9.0 |
| O‘rtacha ball | 6.4 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | 2.9 | 78.09 | 78.28 | -92.14 | 6.3 |
| Yil/Yil | 16.83 | 4.56 | 55.23 | 41.7 | 8.3 |
| 3 yil o‘rtacha | -2.32 | -32.15 | 11.73 | 13.79 | 4.3 |
| 5 yil o‘rtacha | 12.4 | -18.57 | 10.43 | 7 | 5.0 |
| O‘rtacha ball | 6.0 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |
Umumiy qarz $230.9M naqd pul zahiralaridan ($90.8M) sezilarli darajada ko'p bo'lib, moliyaviy barqarorlik xavotirlarini keltirib chiqaradi
Jami joriy aktivlar $126.3M jami joriy majburiyatlardan $117.3M ko'p bo'lib, ajoyib likvidlikni ta'kidlaydi
Qarz/kapital nisbati (-0.9) tarmoq o'rtachasidan (0.3) sezilarli past bo'lib, ehtiyotkor moliyaviy boshqaruvni namoyish etadi
Foiz qoplash koeffitsiyenti (-2.1x) xavfli darajada past bo'lib, qarzni qaytarish xavflarini ko'rsatadi
Salbiy erkin pul oqimi -$22.7M kompaniyaning qayta investitsiya qilish yoki qarzni to'lash qobiliyatini cheklaydi